Seattle Genetics Inc. (SGEN) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Seattle Genetics Inc. (NASDAQ: SGEN) reported Q2 EPS of ($0.14), $0.09 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $68.3 million versus the consensus estimate of $65.04 million.
For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
